| Original language | English |
|---|---|
| Pages (from-to) | 1742-1746 |
| Number of pages | 5 |
| Journal | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |
| Volume | 57 |
| Issue number | 12 |
| DOIs | |
| State | Published - Dec 2013 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 57, No. 12, 12.2013, p. 1742-1746.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Developing a new, national approach to surveillance for ventilator-associated events
T2 - executive summary.
AU - Magill, Shelley S.
AU - Klompas, Michael
AU - Balk, Robert
AU - Burns, Suzanne M.
AU - Deutschman, Clifford S.
AU - Diekema, Daniel
AU - Fridkin, Scott
AU - Greene, Linda
AU - Guh, Alice
AU - Gutterman, David
AU - Hammer, Beth
AU - Henderson, David
AU - Hess, Dean
AU - Hill, Nicholas S.
AU - Horan, Teresa
AU - Kollef, Marin
AU - Levy, Mitchell
AU - Septimus, Edward
AU - Vanantwerpen, Carole
AU - Wright, Don
AU - Lipsett, Pamela
N1 - Funding Information: Supported by the Centers for Disease Control and Prevention (CDC). Funding Information: Conflicts of interest: Dr Klompas received grant support from the CDC, US Food and Drug Administration , and the Office of the National Co-ordinator for Health IT . Dr Balk received grant support from the CDC and bioMérieux for participation in the EPIC CAP study (CDC) and the Procalcitonin in ICU antibiotic stewardship study (CDC and bioMérieux). Dr Deutschman received grant support from the National Institute of General Medical Sciences . Dr Diekema received grant support from Merck, Cerexa, bioMériuex, PurThread Technologies, and Pfizer . Dr Klompas received support for travel from the CDC, Society of Healthcare Epidemiologists of America, Association for Professionals in Infection Control and Epidemiology , and the Duke University Infection Control Outreach Network . Dr Balk received support for travel from the CDC and Critical Care Societies Collaborative . Dr Burns received support for travel from the American Association of Critical-Care Nurses (AACN; meeting unrelated to this study). Drs Deutschman and Lipsett received support for travel from the Society of Critical Care Medicine . Ms Greene received support for travel from the Department of Health and Human Services/CDC. Ms Greene consults for INC . Dr Hess consulted for Philips Respironics, ResMed, Pari, and Breathe and received honorarium from Covidien and Maquet . Ms Greene lectured for Premier, Advanced Sterilization Products, and APIC. Dr Burns lectured for AACN (annual national conference). Ms Greene presented speeches for Covidien and Maquet. Dr Septimus received an honorarium for a lecture. Dr Klompas received support from the Society of Healthcare Epidemiologists of America for the development of educational presentations. Ms Greene is employed by the Rochester General Hospital. Dr Lipsett has board membership with the Society of Critical Care Medicine. Dr Deutschman received a stipend for his Presidency with the Society of Critical Care Medicine . Dr Deutschman received royalties from Elsevier for the textbook, Evidence-based Practice of Critical Care Medicine. Dr Burns receives royalties from McGraw-Hill for books endorsed by AACN. Ms Greene receives royalties from Up-To-Date, Jones and Bartlett, and McGraw-Hill . The remaining authors disclose no conflicts.
PY - 2013/12
Y1 - 2013/12
UR - http://www.scopus.com/inward/record.url?scp=84901282949&partnerID=8YFLogxK
U2 - 10.1093/cid/cit577
DO - 10.1093/cid/cit577
M3 - Article
C2 - 24280662
AN - SCOPUS:84901282949
SN - 1058-4838
VL - 57
SP - 1742
EP - 1746
JO - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
JF - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
IS - 12
ER -